Lyra Therapeutics doubles Executive Chair salary to $400k retroactive to Jan 1, 2024

Lyra Therapeutics, Inc.

Board approved salary increase for Executive Chair Harlan Waksal from $200k to $400k annually.
Increase is retroactive to January 1, 2024.
No other compensation changes for officers were disclosed in the filing.

item 5.02

Lyra Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-023918

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.